Concepedia

Welby Montalvo-Ortiz

WM

Statistics

Publications

5

Citations

1.8K

H-Index

5

Active since

2013

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

The University of Texas MD Anderson Cancer Center

Regeneron (United States)

Welby Montalvo-Ortiz is an author at Memorial Sloan Kettering Cancer Center specializing in cancer immunotherapy, immunology, and cancer immunology.

ORCID

Publications per year

2013–2022

5

Publications

5

Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma

Tyler R. Simpson, Fubin Li, Welby Montalvo-Ortiz et al. · The Journal of Experimental Medicine · 2013 · 1.5K citations

, , +17

Sequence of αPD-1 relative to local tumor irradiation determines the induction of abscopal antitumor immune responses

Joyce Wei, Welby Montalvo-Ortiz, Lola Yu et al. · Science Immunology · 2021 · 158 citations

, , +12

Cytotoxic T Lymphocyte Antigen-4 Blockade Enhances Antitumor Immunity by Stimulating Melanoma-Specific T-cell Motility

Tsvetelina Pentcheva‐Hoang, Tyler R. Simpson, Welby Montalvo-Ortiz et al. · Cancer Immunology Research · 2014 · 79 citations

, , +17

CD22-targeted CD28 bispecific antibody enhances antitumor efficacy of odronextamab in refractory diffuse large B cell lymphoma models

Joyce Wei, Welby Montalvo-Ortiz, Lola Yu et al. · Science Translational Medicine · 2022 · 52 citations

, , +17

Friends Not Foes: CTLA-4 Blockade and mTOR Inhibition Cooperate during CD8+ T Cell Priming To Promote Memory Formation and Metabolic Readiness

Virginia A. Pedicord, Justin R. Cross, Welby Montalvo-Ortiz et al. · The Journal of Immunology · 2015 · 45 citations · Full text

, , +17

1–5 of 5